IP Library Granted Patent US 11,147,926
Granted Patent B2
US 11,147,926 · App. 15/014,893 · Granted Oct 19, 2021

Intrathecal baclofen pharmaceutical dosage forms and related delivery system

Inventors: John J. Foster (Stillwater, MN); Thomas R. Prentice (Lake Elmo, MN)
Assignee: PIRAMAL CRITICAL CARE, INC.
A61M5/31535A61K9/0019A61K9/0085A61K31/197A61K47/02A61M5/31A61M5/315A61M2005/3114A61M2005/3125A61M2205/6009A61M2205/6081
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,147,926
App. No.
15/014,893
Granted
Oct 19, 2021
Kind
B2
Abstract

According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.

Claims (10)

1. A process for preparation of drug delivery system consisting of a packaged and labeled syringe pre-filled with a sterile solution of baclofen containing up to 0.5% by weight of (4-chlorophenyl)-2-pyrrolidone, for intrathecal delivery comprising the steps of:

(i) adding sodium chloride solution to baclofen, wherein the baclofen is not filtered, to form a solution of baclofen having a concentration of 0.5 mg/ml, 2.0 mg/ml, or 3.0 mg/ml, wherein the pH of the baclofen solution is in the range of about 4.5 to about 8.0 or about 5.0 to about 7.0;

(ii) sterilizing the solution of baclofen obtained in step (i) by steam heating at 121° C. so that the sterilization time (F 0 ) for the resulting terminally sterilized solution is 7 minutes;

(iii) filling a syringe with 5 ml to 40 ml of the sterile solution of step (ii) and wherein the syringe has an internal surface treated to reduce reactivity of the internal surface;

(iv) color coding a plunger and/or label of the syringe depending on the amount of said baclofen in said pre-filled syringe; and

(v) closing a dispensing end of the syringe with a leur-lock tip, thereby forming the packaged and labeled pre-filled syringe.

2. The process of claim 1 , wherein said color coding system is on said plunger.

3. The process of claim 1 , wherein said color coding system is on the plunger and a label of said packaged and labeled pre-filled syringe.

4. The process of claim 3 , wherein said color coding system is on a label of said packaged and labeled pre-filled syringe.

5. The process of claim 1 , wherein said color coding system is also indicative of the amount of said baclofen in said pre-filled syringe.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 16, 2026
From: HSBC BANK USA, NATIONAL ASSOCIATION
To: PIRAMAL CRITICAL CARE, INC.
Reel/Frame 074083/0930 →
SECURITY INTEREST Recorded Dec 23, 2022
From: PIRAMAL CRITICAL CARE, INC.
To: HSBC BANK USA, NATIONAL ASSOCIATION, AS SECURITY AGENT
Reel/Frame 062195/0373 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 050225/0138 Recorded Sep 29, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: PIRAMAL CRITICAL CARE, INC.
Reel/Frame 061569/0097 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2019
From: PIRAMAL CRITICAL CARE LIMITED
To: PIRAMAL CRITICAL CARE, INC.
Reel/Frame 050256/0158 →
SECURITY INTEREST Recorded Aug 30, 2019
From: PIRAMAL CRITICAL CARE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 050225/0138 →
RELEASE OF SECURITY INTEREST Recorded Aug 28, 2019
From: STANDARD CHARTERED BANK
To: PIRAMAL CRITICAL CARE LIMITED
Reel/Frame 050201/0397 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNOR, SHOULD BE PIRAMAL CRITICAL CARE LIMITED PREVIOUSLY RECORDED ON REEL 046181 FRAME 0425. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 18, 2018
From: PIRAMAL CRITICAL CARE LIMITED
To: STANDARD CHARTERED BANK
Reel/Frame 047949/0237 →
SECURITY AGREEMENT Recorded Jun 1, 2018
From: PIRAMEL CRITICAL CARE LIMITED
To: STANDARD CHARTERED BANK
Reel/Frame 046181/0425 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2017
From: MALLINCKRODT LLC
To: PIRAMAL CRITICAL CARE LIMITED
Reel/Frame 042612/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 3, 2016
From: FOSTER, JOHN J.; PRENTICE, THOMAS R.
To: MALLINCKRODT LLC
Reel/Frame 039323/0525 →
Continuity (7)
Continuation 14725714 · May 29, 2015
Continuation In Part 12403190 · Mar 12, 2009
Continuation In Part 14574733 · Dec 18, 2014
Continuation 12701342 · Feb 5, 2010
Provisional Application 61037544 · Mar 18, 2008
Provisional Application 61150337 · Feb 6, 2009
Related Publication 20160151575A1 · Jun 2, 2016